Ingevity NGVT Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$127.8M+23.5% | -$167.1M-103% | -$82.5M+64.6% | -$233.2M+37.0% | -$370.4M+17.1% | ||
| $104.2M-2.1% | $106.4M+2.6% | $103.7M+1.8% | $101.9M-1.6% | $103.6M-4.3% | ||
| $19M+3.8% | $18.3M+15.1% | $15.9M+16.1% | $13.7M+17.1% | $11.7M-1.7% | ||
| $303.8M-8.3% | $331.2M+10.9% | $298.6M+38.6% | $215.4M+29.7% | $166.1M+29.2% | ||
| $58M+0.5% | $57.7M-2.2% | $59M-9.4% | $65.1M-8.3% | $71M-8.5% | ||
| $60.3M+205% | -$57.5M+18.3% | -$70.4M-17.9% | -$59.7M+20.1% | -$74.7M+6.0% | ||
| —— | —— | —— | —— | $0— | ||
| $912.8M+213% | $291.3M-37.2% | $463.5M+4.7% | $442.8M+6.6% | $415.4M+2.7% | ||
| $1.1B+128% | $483.6M+110% | $230.7M+57.8% | $146.2M+223% | $45.3M— | ||
| -$303M-20.1% | -$252.2M+5.3% | -$266.4M-49.7% | -$177.9M-70.1% | -$104.6M-49.0% | ||
| $66.2M+138% | $27.8M+171% | -$39.1M-115% | -$18.2M-28.2% | -$14.2M+43.9% | ||
| $245.8M-10.1% | $273.5M+14.1% | $239.6M+59.4% | $150.3M+58.0% | $95.1M+86.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Ingevity's cash flow data come from?
- Every line is extracted from Ingevity's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.